![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/7076 | (2006.01) |
A61K 31/522 | (2006.01) | ||
A61K 31/675 | (2006.01) | ||
A61K 33/24 | (2019.01) | ||
A61K 45/06 | (2006.01) | ||
C07H 19/20 | (2006.01) | ||
A61P 31/20 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 27/02 | (2006.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 29/00 | (2006.01) |
(11) | Number of the document | 3416654 |
(13) | Kind of document | T |
(96) | European patent application number | 17708104.9 |
Date of filing the European patent application | 2017-02-17 | |
(97) | Date of publication of the European application | 2018-12-26 |
(45) | Date of publication and mention of the grant of the patent | 2021-10-27 |
(46) | Date of publication of the claims translation | 2022-01-10 |
(86) | Number | PCT/US2017/018253 |
Date | 2017-02-17 |
(87) | Number | WO 2017/143113 |
Date | 2017-08-24 |
(30) | Number | Date | Country code |
201662296665 P | 2016-02-18 | US | |
201662428721 P | 2016-12-01 | US |
(72) |
SHALWITZ, Robert , US
|
(73) |
Invirsa, Inc. ,
1275 Kinnear Road, Columbus OH 43212,
US
|
(74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | 5’-Adenozindifosfato ribozės (ADPR) medicininis panaudojimas |
MEDICAL USE OF 5'-ADENOSINE DIPHOSPHATE RIBOSE (ADPR) |
Payment date | Validity (years) | Amount | |
2025-01-23 | 9 | 208.00 EUR |
2026-02-17 |